Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/176703
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCorominas Castiñeira, Roser-
dc.contributor.authorRibasés Haro, Marta-
dc.contributor.authorCamina, Montserrat-
dc.contributor.authorCuenca León, Ester-
dc.contributor.authorPardo, Julio-
dc.contributor.authorBoronat, Susana-
dc.contributor.authorSobrido, Maria Jesús-
dc.contributor.authorCormand Rifà, Bru-
dc.contributor.authorMacaya, Alfons-
dc.date.accessioned2021-04-26T14:02:26Z-
dc.date.available2021-04-26T14:02:26Z-
dc.date.issued2009-
dc.identifier.issn1471-2350-
dc.identifier.urihttp://hdl.handle.net/2445/176703-
dc.description.abstractBackground We previously reported risk haplotypes for two genes related with serotonin and dopamine metabolism: MAOA in migraine without aura and DDC in migraine with aura. Herein we investigate the contribution to migraine susceptibility of eight additional genes involved in dopamine neurotransmission. Methods We performed a two-stage case-control association study of 50 tag single nucleotide polymorphisms (SNPs), selected according to genetic coverage parameters. The first analysis consisted of 263 patients and 274 controls and the replication study was composed by 259 cases and 287 controls. All cases were diagnosed according to ICHD-II criteria, were Spanish Caucasian, and were sex-matched with control subjects. Results Single-marker analysis of the first population identified nominal associations of five genes with migraine. After applying a false discovery rate correction of 10%, the differences remained significant only for DRD2 (rs2283265) and TH (rs2070762). Multiple-marker analysis identified a five-marker T-C-G-C-G (rs12363125-rs2283265-rs2242592-rs1554929-rs2234689) risk haplotype in DRD2 and a two-marker A-C (rs6356-rs2070762) risk haplotype in TH that remained significant after correction by permutations. These results, however, were not replicated in the second independent cohort. Conclusion The present study does not support the involvement of the DRD1, DRD2, DRD3, DRD5, DBH, COMT, SLC6A3 and TH genes in the genetic predisposition to migraine in the Spanish population.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/1471-2350-10-95-
dc.relation.ispartofBMC Medical Genetics, 2009, vol. 10, p. 95-
dc.relation.urihttps://doi.org/10.1186/1471-2350-10-95-
dc.rightscc-by (c) Corominas Castiñeira, Roser et al., 2009-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)-
dc.subject.classificationMigranya-
dc.subject.classificationDopamina-
dc.subject.classificationGenètica-
dc.subject.otherMigraine-
dc.subject.otherDopamine-
dc.subject.otherGenetics-
dc.titleTwo-stage case-control association study of dopamine-related genes and migraine-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec588216-
dc.date.updated2021-04-26T14:02:26Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid19772578-
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
588216.pdf262.88 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons